SE428684B - Analogiforfarande for framstellning av substituerade (3-lagalkylamino-2-hydroxi-propoxi)pyridiner - Google Patents

Analogiforfarande for framstellning av substituerade (3-lagalkylamino-2-hydroxi-propoxi)pyridiner

Info

Publication number
SE428684B
SE428684B SE7706181A SE7706181A SE428684B SE 428684 B SE428684 B SE 428684B SE 7706181 A SE7706181 A SE 7706181A SE 7706181 A SE7706181 A SE 7706181A SE 428684 B SE428684 B SE 428684B
Authority
SE
Sweden
Prior art keywords
lagalkylamino
pyridines
propoxy
hydroxy
preparing substituted
Prior art date
Application number
SE7706181A
Other languages
English (en)
Swedish (sv)
Other versions
SE7706181L (sv
Inventor
J J Baldwin
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of SE7706181L publication Critical patent/SE7706181L/xx
Publication of SE428684B publication Critical patent/SE428684B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/70—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/70—Sulfur atoms
    • C07D213/71—Sulfur atoms to which a second hetero atom is attached

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7706181A 1976-06-15 1977-05-26 Analogiforfarande for framstellning av substituerade (3-lagalkylamino-2-hydroxi-propoxi)pyridiner SE428684B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/696,237 US4060601A (en) 1976-06-15 1976-06-15 Certain lower-alkyl amino-2'-hydroxy-propoxy pyridines

Publications (2)

Publication Number Publication Date
SE7706181L SE7706181L (sv) 1977-12-16
SE428684B true SE428684B (sv) 1983-07-18

Family

ID=24796255

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7706181A SE428684B (sv) 1976-06-15 1977-05-26 Analogiforfarande for framstellning av substituerade (3-lagalkylamino-2-hydroxi-propoxi)pyridiner

Country Status (9)

Country Link
US (2) US4060601A (es)
JP (1) JPS52153971A (es)
CH (1) CH632495A5 (es)
DE (1) DE2726796A1 (es)
DK (1) DK236377A (es)
FR (1) FR2361370A1 (es)
GB (1) GB1549132A (es)
NL (1) NL7705881A (es)
SE (1) SE428684B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4410530A (en) * 1973-02-20 1983-10-18 Ciba-Geigy Corporation 2-(3-Amino-2-hydroxy-propoxy)-mono-and diazines
US4195090A (en) * 1973-02-20 1980-03-25 Ciba-Geigy Corporation 2-(3-Amino-2-hydroxy-propoxy)pyridine derivatives and pharmaceutical compositions therewith
US4000282A (en) * 1974-12-16 1976-12-28 Merck & Co., Inc. 2-(3-tert. butyl or isopropylamino-2-hydroxypropoxy)-3-cyanopyridines
US4053605A (en) * 1976-06-15 1977-10-11 Merck & Co., Inc. Esterified-2(3-lower-alkyl-amino-propoxy)-3-cyano-pyridines and derivatives
US4091104A (en) * 1976-06-15 1978-05-23 Merck & Co., Inc. Substituted (3-loweralkylamino-2-R1 O-propoxy)pyridines, their preparation and use
DE2711655A1 (de) * 1977-03-17 1978-09-21 Basf Ag Pyridinyl-aminoalkylaether
US4144343A (en) * 1978-01-04 1979-03-13 Merck & Co., Inc. Heterocycle substituted (3-loweralkylamino-2-R1 O-propoxy)pyridines
US4279913A (en) * 1978-01-04 1981-07-21 Merck & Co., Inc. Polysubstituted-2-(3-loweralkylamino-2-R1 O-propoxy)pyridines
JPS54106476A (en) * 1978-01-04 1979-08-21 Merck & Co Inc Multiisubstituted 22*33lower alkylaminoo22 r100propoxy*pyridine
US4393212A (en) * 1979-01-29 1983-07-12 Merck & Co., Inc. Certain nicotinic acid esters and corresponding nicotinonitriles
US4234590A (en) * 1979-02-05 1980-11-18 Merck & Co., Inc. Thiosubstituted pyridines
US4259327A (en) * 1979-04-02 1981-03-31 Merck & Co., Inc. Substituted aminoalkoxypyridines, compositions and use thereof
US4330546A (en) * 1979-09-14 1982-05-18 John Wyeth & Brother Limited 3-Aryl-3-aryloxypropylamines
US4329351A (en) * 1979-10-01 1982-05-11 Merck & Co., Inc. 2-Substituted propoxy-3-cyano-5-RO-pyridines and intermediates
JPS5798262A (en) * 1980-12-10 1982-06-18 Yoshitomi Pharmaceut Ind Ltd Pyridine derivative
ES523901A0 (es) * 1983-07-06 1985-04-01 Fabr Prod Quimicos Y Farmaceut Un procedimiento para la preparacion de derivados de 3-sulfonamidopiridinas 2 -sustituidas.

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3459782A (en) * 1963-08-26 1969-08-05 Boehringer Sohn Ingelheim 1-substituted phenoxy-2-hydroxy-3-isopropylamino-propanes
FR1576539A (es) * 1968-05-21 1969-08-01
US3655663A (en) * 1969-04-21 1972-04-11 Burton K Wasson 4-(3-secondary amino-2-hydroxy-proxy) 1 2 5-thiadiazoles
CA1001631A (en) * 1972-05-05 1976-12-14 Merck Sharp And Dohme (I.A.) Corp. 2-(3-substituted amino-2-hydroxy-propoxy)-3-substituted pyrazines and method for preparation
US3946009A (en) * 1972-05-05 1976-03-23 Merck Sharp & Dohme (I.A.) Corporation 2-(3-Substituted amino-2-hydroxypropoxy)-3-substituted pyrazines
LU65414A1 (es) * 1972-05-24 1973-12-04
AR207133A1 (es) * 1973-02-20 1976-09-15 Ciba Geigy Ag Procedimiento para la elaboracion de derivados de 1-piridiloxi 1-pirimidiniloxi y 1-piraziniloxi-2-hidroxi-3-amino-propano
LU69043A1 (es) * 1973-12-20 1975-08-20
DE2507902A1 (de) * 1974-04-02 1975-10-09 Ciba Geigy Ag Neue amine und verfahren zu ihrer herstellung
US4000282A (en) * 1974-12-16 1976-12-28 Merck & Co., Inc. 2-(3-tert. butyl or isopropylamino-2-hydroxypropoxy)-3-cyanopyridines
GB1485919A (en) * 1975-08-12 1977-09-14 Grindstedvaerket As Pyridine derivatives

Also Published As

Publication number Publication date
JPS52153971A (en) 1977-12-21
JPS6341904B2 (es) 1988-08-19
DK236377A (da) 1977-12-16
US4125618A (en) 1978-11-14
CH632495A5 (de) 1982-10-15
SE7706181L (sv) 1977-12-16
FR2361370B1 (es) 1979-10-12
FR2361370A1 (fr) 1978-03-10
DE2726796A1 (de) 1977-12-29
US4060601A (en) 1977-11-29
GB1549132A (en) 1979-08-01
NL7705881A (nl) 1977-12-19

Similar Documents

Publication Publication Date Title
SE431753B (sv) Analogifprfarande for framstellning av 2-piperazinyl-6,7-dimetoxikinazoliner
RO70569A (ro) Procedeu pentru prepararea alchilaminelor heterociclice
SE440791B (sv) Forfarande for upparbetning av lignitkol
SE430335B (sv) Analogiforfarande for framstellning av pyridinyl-pyridinoner
SE440501B (sv) Forfarande for framstellning av substituerade fenylamidoximer
SE442400B (sv) Forfarande for framstellning av nya 1-aryloxi-2-hydroxi-3-alkylenaminopropaner
SE432595B (sv) Analogiforfarande for framstellning av piperidyl-indolderivat
NO773548L (no) Fremgangsmaate for fremstilling av spiro-hydantoinderivater
DK145228C (da) Analogifremgangsmaade til fremstilling af 3-amino-4-deoxo-4-iminorifamycinderivater
DK147068C (da) Analogifremgangsmaade til fremstilling af 1-naphthylmethyl-cinnamyl-aminderivater
SE428684B (sv) Analogiforfarande for framstellning av substituerade (3-lagalkylamino-2-hydroxi-propoxi)pyridiner
SE438856B (sv) Analogiforfarande for framstellning av 1-acyloximetyl-3-fluoruracilderivat
SE428685B (sv) Analogiforfarande for framstellning av cyanosubstituerade (3-lagalkylamino-2-acyl-0-propoxi)pyridiner
SE433212B (sv) Forfarande for framstellning av 4-hydroxi-aporfin-derivat
SE431871B (sv) Forfarande for framstellning av 2-brom-6-fluor-n-2-imidazolidinylidenbensamin
SE7613768L (sv) Forfarande for framstellning av penicillinestrar
SE428296B (sv) Analogiforfarande for framstellning av substituerade difonylsulfider
SE433219B (sv) Forfarande for framstellning av 3-halogenmetylcefalosporinforeningar
DK153489C (da) Analogifremgangsmaade til fremstilling af 7-aminothiazolylacetamidocephalosporansyrederivater
SE443140B (sv) Forfarande for framstellning av karbostyrilderivat
SE431336B (sv) Analogiforfarande for framstellning av substituerade 8-azapurinderivat
DK150484C (da) Analogifremgangsmaade til fremstilling af 4-amino-3-thiophencarboxylsyrederivater
SE421125B (sv) Forfarande for framstellning av 5-m-tolyloxiuracil
DK128277A (da) Fremgangsmade til fremstilling af pyridinderivater
NO773073L (no) Fremgangsmaate for fremstilling av 2-piperazinyl-kinazolinderivater